Detalhe da pesquisa
1.
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
Cell
; 184(18): 4713-4733.e22, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34352228
2.
Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.
Am J Gastroenterol
; 116(8): 1638-1645, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047305
3.
An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection.
Microbiol Spectr
; 12(6): e0351623, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687064
4.
Severe COVID-19 is associated with fungal colonization of the nasopharynx and potent induction of IL-17 responses in the nasal epithelium.
medRxiv
; 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324802
5.
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Gut Microbes
; 13(1): 1-15, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34100340
6.
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
bioRxiv
; 2021 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619488
7.
Examination of gene expression in saliva samples from COVID-19 patients to study the host defense response against SARS-CoV-2 in the oral cavity.
Mol Oral Microbiol
; 36(2): 157-158, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34527214